BNP Paribas Asset Management Holding S.A. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2024$2,884
+3.1%
1,600,0000.0%0.01%0.0%
Q4 2023$2,798
-39.5%
1,600,000
-48.4%
0.01%
-42.9%
Q3 2023$4,628
+17.5%
3,100,0000.0%0.01%
+16.7%
Q2 2023$3,940
-4.7%
3,100,0000.0%0.01%
-14.3%
Q1 2023$4,133
-15.5%
3,100,0000.0%0.01%
-22.2%
Q4 2022$4,894
-99.9%
3,100,0000.0%0.02%
+5.9%
Q3 2022$4,352,000
+6.1%
3,100,0000.0%0.02%
+6.2%
Q2 2022$4,102,000
+0.7%
3,100,0000.0%0.02%
+14.3%
Q1 2022$4,075,000
+5.7%
3,100,0000.0%0.01%
+7.7%
Q4 2021$3,855,000
-6.7%
3,100,0000.0%0.01%
-13.3%
Q3 2021$4,133,000
+0.3%
3,100,0000.0%0.02%0.0%
Q2 2021$4,121,000
-1.5%
3,100,0000.0%0.02%
-11.8%
Q1 2021$4,185,000
-2.9%
3,100,0000.0%0.02%
-15.0%
Q4 2020$4,310,000
+0.9%
3,100,0000.0%0.02%
-16.7%
Q3 2020$4,273,000
-17.0%
3,100,0000.0%0.02%
-31.4%
Q2 2020$5,146,000
-12.4%
3,100,000
-32.6%
0.04%
-30.0%
Q1 2020$5,872,000
-16.5%
4,600,0000.0%0.05%
+4.2%
Q4 2019$7,034,000
+11.5%
4,600,0000.0%0.05%
-2.0%
Q3 2019$6,311,000
-14.5%
4,600,000
-17.9%
0.05%
-18.3%
Q2 2019$7,384,000
-2.6%
5,600,0000.0%0.06%
-4.8%
Q1 2019$7,583,000
-9.2%
5,600,000
-21.4%
0.06%
-18.2%
Q4 2018$8,354,000
-49.9%
7,125,000
-26.7%
0.08%
-39.8%
Q3 2018$16,680,000
+18.8%
9,725,0000.0%0.13%
+8.5%
Q2 2018$14,037,0009,725,0000.12%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
SSI INVESTMENT MANAGEMENT LLC 7,440,000$10,058,0000.84%
SHENKMAN CAPITAL MANAGEMENT INC 4,121,000$5,579,0000.72%
Baker Brothers Advisors 53,270,000$71,994,0000.46%
LINDEN ADVISORS LP 11,675,000$15,814,0000.36%
ADVENT CAPITAL MANAGEMENT /DE/ 11,558,000$15,650,0000.34%
AQR Arbitrage LLC 20,000,000$27,077,0000.34%
CSS LLC/IL 3,455,000$4,675,0000.28%
RWC Asset Management LLP 4,000,000$5,396,0000.25%
MACKAY SHIELDS LLC 21,460,000$29,043,0000.21%
Calamos Advisors LLC 24,105,000$32,660,0000.20%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders